LD2201

An Act to Implement Certain Recommendations Related to the Regulatory Review and Approval of Certain Health Care Transactions Involving Private Equity Companies, Hedge Funds or Management Services Organizations from the Commission to Evaluate the Scope of Regulatory Review and Oversight over Health Care Transactions That Impact the Delivery of Health Care Services in the State

Complete·4/8/26

Maine LD2201 implements recommendations for reviewing health care transactions involving private equity, hedge funds, or management services.

Maine LD2201 establishes a regulatory review process for material change transactions involving health care entities and private equity companies, hedge funds, or management services organizations. The bill requires health care entities to submit written notice to the department at least 180 days before completing any material change transaction. The notice must include details about the transaction, its impact on health care services, and geographic service areas of affected hospitals.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Sponsors

D
1
0
Democratic CaucusRepublican Caucus

Calendar

Feb 25

10:00 AM

Hearing

Feb 18

10:01 AM

Hearing

History

Apr 8

House

PASSED TO BE ENACTED.

Apr 8

House

Sent for concurrence. ORDERED SENT FORTHWITH.

Apr 8

Senate

PASSED TO BE ENACTED, in concurrence.